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ABSTRACT The cell wall provides a major physical interface between fungal patho-
gens and their mammalian host. This extracellular armor is critical for fungal cell
homeostasis and survival. Fungus-specific cell wall moieties, such as -1,3-glucan,
are recognized as pathogen-associated molecular patterns (PAMPs) that activate
immune-mediated clearance mechanisms. We have reported that the opportunistic
human fungal pathogen Candida albicans masks -1,3-glucan following exposure to
lactate, hypoxia, or iron depletion. However, the precise mechanism(s) by which C.
albicans masks -1,3-glucan has remained obscure. Here, we identify a secreted exo-
glucanase, Xog1, that is induced in response to lactate or hypoxia. Xog1 functions
downstream of the lactate-induced -glucan “masking” pathway to promote -1,3-
glucan “shaving.” Inactivation of XOG1 blocks most but not all -1,3-glucan masking
in response to lactate, suggesting that other activities contribute to this phenome-
non. Nevertheless, XOG1 deletion attenuates the lactate-induced reductions in
phagocytosis and cytokine stimulation normally observed for wild-type cells. We also
demonstrate that the pharmacological inhibition of exoglucanases undermines
-glucan shaving, enhances the immune visibility of the fungus, and attenuates its
virulence. Our study establishes a new mechanism underlying environmentally in-
duced PAMP remodeling that can be manipulated pharmacologically to influence
immune recognition and infection outcomes.
IMPORTANCE The immune system plays a critical role in protecting us against po-
tentially fatal fungal infections. However, some fungal pathogens have evolved eva-
sion strategies that reduce the efficacy of our immune defenses. Previously, we re-
ported that the fungal pathogen Candida albicans exploits specific host-derived
signals (such as lactate and hypoxia) to trigger an immune evasion strategy that in-
volves reducing the exposure of -glucan at its cell surface. Here, we show that this
phenomenon is mediated by the induction of a major secreted exoglucanase (Xog1)
by the fungus in response to these host signals. Inactivating XOG1-mediated “shav-
ing” of cell surface-exposed -glucan enhances immune responses against the fun-
gus. Furthermore, inhibiting exoglucanase activity pharmacologically attenuates C.
albicans virulence. In addition to revealing the mechanism underlying a key immune
evasion strategy in a major fungal pathogen of humans, our work highlights the po-
tential therapeutic value of drugs that block fungal immune evasion.
KEYWORDS Candida albicans, cell wall, Xog1 exoglucanase, -glucan shaving,
immune evasion, castanospermine, virulence
Life-threatening fungal infection outcomes are affected by the efficacy of the im-mune system in recognizing and clearing potential invaders (1). Fungal diseases
cause more than 1 million deaths worldwide annually (2). Candida species are a leading
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cause of life-threatening fungal infections, and Candida albicans is the species respon-
sible for the majority of these Candida infections (2). C. albicans is an obligate com-
mensal of warm-blooded animals that causes opportunistic mucosal and systemic
infections in immunocompromised patients and other susceptible populations, includ-
ing individuals requiring abdominal surgery or long-term intensive care (3). The success
of C. albicans as a fungal pathogen is widely attributed to virulence factors such as its
ability to undergo a reversible morphological transition between yeast and filamentous
cells, the production of adhesins, secreted proteases and candidalysin, and the ability
to evade immune killing (4–6).
Host clearance mechanisms are initiated via pathogen-associated molecular pattern
(PAMP) recognition by pattern recognition receptors (PRRs) (7). The fungal cell wall is
the primary point of direct contact with host cells, and it plays a key role in immune
recognition (8). Fungal cell walls contain major PAMPs that can induce inflammatory or
tolerogenic processes (7, 9). -1,3-Glucan, in particular, is highly inflammatory. In C.
albicans, most -1,3-glucan is located in the inner cell wall and is masked from immune
recognition by the outer layer of mannan fibrils (10). When -1,3-glucan becomes
exposed at the cell surface, it is recognized by the C-type lectin dectin-1 (11), and this
PAMP-PRR interaction plays a key role in antifungal immunity (11–14).
C. albicans presents a moving immunological target to the host. For example, C.
albicans cells reduce the exposure of -1,3-glucan at their cell surface in response to
specific host signals. When C. albicans is exposed to L-lactate, a metabolite generated
by cells of the host and its microbiota, the fungus activates signaling via the conserved
G-protein coupled receptor (GPCR), Gpr1, and the transcription factor, Crz1 (15). This
culminates in decreased -1,3 glucan exposure and impacts host immune responses by
reducing phagocytosis and cytokine production by innate immune cells. Additional
host-relevant conditions, including hypoxia, shifts in ambient pH, and iron starvation,
influence cell wall architecture and PAMP exposure (16–18). However, the mechanisms
governing -1,3 glucan masking in C. albicans have proven elusive.
In this study, we utilized proteomics to identify a secreted exo--1,3-glucanase,
Xog1, that acts in trans to mediate lactate-induced -glucan masking in C. albicans. We
show that deletion of XOG1, or pharmacological inhibition of exoglucanase, inhibits
lactate-induced -glucan masking and results in a higher phagocytic uptake by mac-
rophages and cytokine responses of human peripheral blood mononuclear cells
(PBMCs) compared to their wild-type or untreated controls, respectively. Furthermore,
we demonstrate that inhibition of exoglucanase activity attenuates the virulence of
C. albicans in a Galleria mellonellamodel of systemic infection. Taken together, our data
suggest that this major fungal pathogen evades immune recognition and promotes
infection by shaving a major cell surface PAMP.
RESULTS
Extracellular factors mediate -glucan masking. We reasoned that -glucan
masking might be mediated by proteins that are secreted by C. albicans into the milieu
and, if so, these proteins might act in trans to mask -glucan on masking-defective cells.
To test this, we investigated whether culture supernatants from wild-type cells could
functionally complement the defect in lactate-induced -glucan masking displayed by
a masking-deficient czf1 mutant.
CZF1 is a zinc-finger transcription factor that regulates C. albicans contact-
dependent morphogenesis and white-opaque switching (19, 20), and we have reported
that czf1Δ cells display a defect in lactate-induced -glucan masking (15). Therefore,
czf1Δ cells were incubated for 4 h with fresh lactate-containing medium, spent medium
from congenic wild-type C. albicans cells (SC5314), or the same spent medium that had
been boiled and cooled. Their degree of -glucan exposure was quantified by staining
cells with Fc-dectin-1 and analyzing them by flow cytometry. We compared them to
control cells grown on medium lacking lactate. As expected (15), control wild-type C.
albicans cells displayed -glucan in response to lactate, but czf1Δ cells did not (Fig. 1).
However, when the czf1Δ cells were incubated with spent medium from wild-type cells,
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-glucan masking was restored. This effect was abrogated if the spent medium had
been boiled (Fig. 1), suggesting that heat-denaturable factors in wild-type supernatants
are sufficient to rescue -glucan masking in a masking-deficient mutant.
Proteomic fingerprints of -glucan masking. The factors involved in -glucan
masking might be proteins, and C. albicans expresses genes encoding cell wall-
anchored or secreted carbohydrate remodeling enzymes that could mediate -glucan
masking. However, our genome-wide transcriptomic comparisons of lactate-exposed
versus control C. albicans cells did not highlight differentially expressed cell wall genes
that might contribute to -glucan masking (15). Therefore, we reasoned that such
proteins might be subject to posttranscriptional and/or posttranslational regulation. To
address this, we performed unbiased liquid chromatography-tandem mass spectrom-
etry (LC-MS/MS) analysis of the cell wall proteomes and secretomes for control C.
albicans SC5314 cells and compared them to cells undergoing lactate- or hypoxia-
induced -glucan masking.
We identified 213 proteins in the cell wall proteome that were differentially regu-
lated under lactate-induced -glucan masking conditions, and 392 differentially regu-
lated proteins under hypoxic conditions compared to glucose and normoxic controls
(Fig. 2A; see also Fig. S1 in the supplemental material). Fewer proteins were recovered
from the secretome compared to the cell wall proteome, and fewer proteins were
differentially regulated in the secretome (n 79 in total for the lactate and hypoxia
treatments compared to the control) compared to the cell wall proteome (n 526).
We surmised that proteins involved in -glucan masking are likely to be under
positive regulation, and therefore more abundant under masking conditions. Thus, we
focused on the proteins that were induced in response to lactate and/or hypoxia
compared to glucose-grown cells. GO molecular function analyses of the lactate- and
hypoxia-induced proteins (Fig. S1) revealed that hydrolases with activity toward gly-
cosyl bonds were enriched in both lactate and hypoxic cell wall proteomes and
secretomes. Strikingly, the lactate- and hypoxia-induced secretomes displayed enrich-
ment for proteins with glucosidase and glucan exo-1,3--glucosidase activity. Indeed,
three of the four secreted proteins that were induced by both lactate and hypoxia have
characterized or putative glucanase activity (Fig. 2B). Dectin-1 is known to bind
-glucans with chain lengths of 10 or more glucose units (21). This was consistent with
the idea that -glucan “masking” may be driven by glucanase-mediated truncation of
-glucan chain lengths to reduce dectin-1 targets in the cell wall.
The major exoglucanase, Xog1, plays a key role in -glucan masking. C. albicans
encodes three exoglucanases: Xog1, Exg2, and Spr1. EXG2 is induced in response to
FIG 1 An extracellular factor is required for lactate-induced -glucan masking. (A) C. albicans wild-type (WT) SC5314 cells were grown in glucose alone or
glucose plus lactate, while czf1Δ cells were grown in glucose alone and then treated with boiled or untreated culture supernatants from wild-type cells grown
on glucose plus lactate. The -glucan exposure on these cells was assayed by Fc-dectin-1 staining and flow cytometry. Left to right, respectively: wild-type cells,
glucose versus glucose plus lactate; czf1Δ cells, glucose / fresh medium; czf1Δ cells, glucose / wild-type culture supernatant; czf1Δ cells, glucose /
boiled wild-type culture supernatant. The median fluorescence intensity for each population is indicated. (B) Fold changes in -glucan exposure for this
experiment are presented relative to glucose-grown control cells. n  3; *, P 0.05 (one-way ANOVA with Tukey’s post hoc).
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lactate, but exg2Δ cells display only a mild -glucan masking defect (15). Also, our
proteomics experiments provided no evidence of the Spr1 protein under the conditions
examined. Gonzalez and coworkers (22) demonstrated that XOG1 is responsible for the
majority of measurable exoglucanase activity in C. albicans. We found that Xog1 was
the protein that displayed the greatest fold change in abundance in the secretomes of
lactate- and hypoxia-exposed cells (Fig. 2B). Thus, we set out to determine whether
Xog1 plays a role in lactate-induced -glucan masking.
Our previous transcript profiling study suggested that XOG1 is not differentially
expressed in response to lactate in wild-type or crz1Δ cells (15). To test whether the
Xog1 protein is upregulated, we examined Xog1 peptide levels in the secretomes of
wild-type C. albicans SC5314 cells (Fig. 2C). Xog1 peptide levels were significantly
increased under lactate-induced -glucan masking conditions, and Xog1 peptide was
detected at higher levels under hypoxia than control conditions. This suggested that
Xog1 levels are regulated at a posttranscriptional and/or posttranslational level. Fur-
thermore, it was consistent with the idea that Xog1 promotes lactate- and hypoxia-
induced -glucan masking.
C. albicans crz1Δ and gpr1Δ gpa2Δ mutants are defective in -glucan masking (15).
Therefore, using LC-MS/MS, we examined the secretomes of crz1Δ and gpr1Δ gpa2Δ
cells in the presence or absence of lactate. Both crz1Δ and gpr1Δ gpa2Δ cells displayed
significant defects in Xog1 induction in response to lactate (Fig. 2D). Thus, the induction
of Xog1 secretion appears to depend on the same signaling mechanisms that drive
lactate-induced -glucan masking.
Next, we tested the impact of Xog1 inactivation upon exoglucanase levels and
-glucan masking. We sequentially deleted both alleles of XOG1 in the wild-type
FIG 2 The Xog1 protein and exoglucanase activity are upregulated during -glucan masking. (A) Proteomic analysis of cell walls and
secretomes of cells grown in lactate versus the glucose-grown control, and hypoxic cells versus the aerobic-grown control. Venn diagram
of proteins displaying 1.5-fold upregulation in peptide spectral mean (PSM) relative to the control. n 4. (B) Table of extracellular
proteins displaying 1.5-fold upregulation in PSM in lactate-grown or hypoxia-grown cells compared to their respective controls. n 4.
(C) Peptide spectral means for Xog1 from the supernatants of C. albicans cells grown in glucose, glucose plus lactate, and hypoxic
conditions. n 4. (D) Fold change in peptide spectral means for Xog1 in wild-type, crz1Δ, and gpr1Δ gpa2Δ cells grown in glucose plus
lactate compared to glucose alone. n 3 to 4. **, P  0.01, one-way ANOVA with Tukey’s post hoc.
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C. albicans clinical isolate SC5314 to generate heterozygous (xog1Δ/) and homozy-
gous (xog1Δ) mutants (Table S1). We then reintroduced XOG1 into the null mutant to
generate a control reintegrant strain (xog1Δ/XOG1). We measured exoglucanase levels
in culture supernatants for this isogenic strain set in the presence and absence of
lactate. In agreement with previous studies (22, 23), we found that XOG1 encodes the
majority of extracellular exoglucanase activity for C. albicans (Fig. 3A). Furthermore,
unlike the wild-type and reintegrant controls, xog1Δ cells did not show an increase in
extracellular exoglucanase in response to lactate (Fig. 3B).
We then tested whether XOG1 contributes to lactate-induced -glucan masking.
XOG1 deletion does not affect cell wall architecture significantly (22). Nevertheless,
microscopic analyses of dectin-1-stained cells showed that xog1Δ cells displayed a
significant defect in lactate-induced -glucan masking, compared to the wild-type
control (Fig. 4A). Also, this masking defect was suppressed in the reintegrant strain.
Bright Fc-dectin-1 staining was observed around bud/birth scars as well as punctate
foci of -glucan exposure on the rest of the C. albicans cell surface. Following lactate
exposure, both types of feature were less intense in wild-type XOG1 cells, but this
decrease in intensity was not observed for xog1Δ cells (Fig. 4A). These microscopic
observations were then confirmed by cytometric quantification of -glucan exposure in
cell populations. In contrast to the wild-type (XOG1) and reintegrant (xog1Δ/XOG1)
strains, xog1Δ cells displayed a significant defect in lactate-induced -glucan masking
(Fig. 4B and C). Nevertheless, some masking remains, suggesting that, while Xog1 is the
major exoglucanase under the conditions tested (Fig. 3A), other activities might
contribute to lactate-induced reductions in -glucan exposure.
Xog1-mediated masking influences phagocytic interactions and cytokine re-
sponses. The changes in -glucan exposure that accompany adaptation to host-related
environmental inputs often result in altered host-fungus interactions (15–18). Thus, we
tested whether Xog1 influences host recognition of C. albicans cells and their interac-
tion with host innate immune cells.
As predicted elsewhere (15), lactate-exposed wild-type C. albicans cells were phago-
cytosed less frequently by murine bone marrow-derived macrophages (BMDMs) than
untreated control cells (Fig. 5A; Movies S1 and S2). Also following lactate exposure,
FIG 3 Inactivating Xog1 reduces exoglucanase activity and blocks its induction during lactate-induced -glucan masking.
(A) Exoglucanase activity was measured by monitoring PNPG cleavage in the indicated strains grown in glucose or glucose
plus lactate medium. Experiments were performed in biological triplicate and technical duplicate. n 3. **, P 0.01; ****,
P 0.0001, two-way ANOVA with Tukey’s post hoc. (B) Fold change in extracellular exoglucanase activity for an isogenic
set of C. albicans xog1 strains grown in medium containing glucose or glucose plus lactate: wild type (XOG1/XOG1),
heterozygote (XOG1/xog1Δ), homozygous null mutant (xog1Δ/xog1Δ), reintegrant (xog1Δ/xog1Δ/XOG1). n 3. **, P 0.01,
one-way ANOVA with Tukey’s post hoc.
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wild-type cells elicited weaker cytokine responses from human PBMCs, which produced
significantly lower levels of the proinflammatory cytokines IL-6 and TNF- (Fig. 5B and
C). In contrast, xog1Δ cells did not display significant reductions in phagocytic uptake
(Fig. 5A; Movies S3 and S4) or attenuated cytokine responses (Fig. 5B and C) following
lactate exposure. Both phenotypes were restored in xog1Δ/XOG1 reintegrant cells.
These results suggest that Xog1-mediated -glucan remodeling plays an important role
in C. albicans-host interactions. However, the inactivation of XOG1 did not significantly
reduce the virulence of C. albicans in Galleria mellonella (Fig. S2), which was consistent
with findings in the mouse model of systemic candidiasis (22).
Exoglucanase inhibition affects -glucan masking and immune responses. Our
results thus far demonstrate that the XOG1 gene promotes lactate-induced -glucan
masking and influences immune responses to C. albicans. Next, we confirmed that
exoglucanase activity is required for these phenotypes.
Castanospermine is the most potent inhibitor of Saccharomyces cerevisiae and C.
albicans exoglucanase activity characterized to date (24). To confirm that castanosper-
mine inhibits exoglucanase under our experimental conditions, we assayed the effects
of castanospermine upon the extracellular exoglucanase generated by wild-type C.
albicans cells using the chromogenic substrate 4-nitrophenyl--D-glucopyranoside
FIG 4 Inactivation of Xog1 inhibits lactate-induced -glucan masking. (A) Microscopic analysis of -glucan exposure in C. albicans cells grown in glucose or
glucose plus lactate medium: wild type (XOG1/XOG1), homozygous null mutant (xog1Δ/xog1Δ), reintegrant (xog1Δ/xog1Δ/XOG1). Images representative of three
biological replicate experiments. Cells were stained with Fc-dectin-1 for -glucan exposure (green) and concanavalin A for mannan exposure (red); scale bar,
5 m. (B) Flow cytometry plots of -glucan exposure for the indicated strains grown in glucose (red) or glucose plus lactate (blue) from one representative
biological sample of n 3 independent replicates. The median fluorescence intensity for each population is indicated. (C) Fold change in Fc-dectin-1 binding
for glucose plus lactate- versus glucose-grown cells, calculated from experiments such as those shown in panel B. n 5 to 7. Statistical analyses: one-way
ANOVA with Tukey’s post hoc. *, P 0.05.
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(PNPG). As expected (24), castanospermine significantly attenuated extracellular exog-
lucanase activity (Fig. 6A).
We then tested whether castanospermine affects lactate-induced -glucan masking
in C. albicans. Control cells treated with vehicle alone displayed the normal reduction
in -glucan exposure in response to lactate (Fig. 6B). However, cells treated with
castanospermine displayed a significant defect in lactate-induced -glucan masking
compared to the controls, suggesting exoglucanase plays a key role in remodeling
-glucan exposure in response to lactate.
The impact of castanospermine treatment upon immune responses was then tested.
Normally, exposing C. albicans to lactate reduces the ability of BMDMs to phagocytose
the fungus and attenuates the cytokine responses of PBMCs (Fig. 5). However, castano-
spermine abrogated this reduction in BMDM phagocytosis (Fig. 7A; Movies S5 and S6)
as well as the elicitation of TNF- by PBMCs (Fig. 7B). Thus, either deleting XOG1 or
inhibiting exoglucanase significantly attenuates lactate-induced -glucan remodeling
and innate immune evasion.
FIG 5 Exoglucanase-induced -glucan masking impacts macrophage phagocytosis and cytokine elicitation. (A) C. albicans strains were grown in medium
containing glucose or glucose plus lactate, inactivated in thimerosal, and coincubated with murine BMDMs: wild type (XOG1/XOG1), homozygous null mutant
(xog1Δ/xog1Δ). Mean number of C. albicans cells phagocytosed per murine BMDM in 2 h; n 4 mice analyzed in biological triplicate; 200 macrophages
counted per coincubation. *, P 0.05, one-way ANOVA with Tukey’s post hoc. (B and C) The same C. albicans strains, grown in glucose or glucose plus lactate
and inactivated in thimerosal, were coincubated with human PBMCs. IL-6 (B) and TNF- (C) levels were assayed after 24 h. n 3 healthy donors, measured in
duplicate (n 3); *, P 0.05; **, P 0.01, two-way ANOVA with Tukey’s post hoc.
FIG 6 Castanospermine inhibits exoglucanase activity and -glucan masking. (A) The effect of 1 M castanosper-
mine (CAS) upon the extracellular exoglucanase activity expressed by wild-type C. albicans cells grown in glucose
or glucose plus lactate was determined using the PNPG assay. n 3; *, P 0.05, one-way ANOVA with Tukey’s post
hoc. (B) The effect of 1 M castanospermine on the change in -glucan exposure observed for wild-type C. albicans
cells grown in glucose plus lactate versus glucose: no addition, wild type (WT); DMSO, WT  vehicle; castano-
spermine, WT 1 M CAS. n 8. *, P 0.05; **, P  0.01, one-way ANOVA with Tukey’s post hoc.
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Exoglucanase inhibition attenuates virulence. Next, we tested whether exoglu-
canase inhibition affects virulence outcomes during systemic candidiasis. Castanosper-
mine is toxic in mice, inducing both weight loss and lethargy (25, 26), thereby
precluding us from using this drug in the murine model of systemic candidiasis.
Consequently, we used the G. mellonella invertebrate infection model, the outcomes of
which correlate well with mouse survival studies (27). G. mellonella larvae died rapidly
if they were infected with wild-type C. albicans cells and treated with vehicle only
(Fig. 7C). However, infected larvae that were treated postinoculation with one dose of
castanospermine displayed significantly extended survival times and increased survival
rates (Fig. 7C). Larvae treated with castanospermine alone or with saline survived for
the duration of the experiment. Therefore, castanospermine treatment extends host
survival during a lethal challenge with C. albicans. This does not appear to be due to a
loss of fitness, because XOG1 inactivation or treatment with castanospermine does not
inhibit yeast growth (22, 24), and exoglucanase activity is not essential for fitness in vitro
(23). Therefore, castanospermine treatment probably promotes fungal clearance in the
host.
DISCUSSION
The exposure of the proinflammatory PAMP, -1,3-glucan, drives phagocytic uptake
and the release of proinflammatory cytokines, thereby promoting fungal killing and
clearance from host tissues (8). There is no correlation between the thickness of the
inner -glucan-containing layer of the C. albicans cell wall and the degree of -glucan
exposure at the cell surface: hypoxia and iron limitation are both strong triggers of
-glucan masking and yet the former leads to a thin cell wall, while the latter leads to
a thick cell wall (16, 17). Rather, the prevailing paradigm has been that most -glucan
in the inner cell wall of C. albicans is masked by the mannan in the outer layer of the
cell wall (10, 28, 29). Perturbation of the mannan outer layer leads to -glucan exposure
and enhanced immune recognition (10, 30, 31). This model is consistent with immune
evasion strategies in other pathogens. For example, the Cryptococcus neoformans cell
wall is coated with a glucuronoxylomannan polysaccharide capsule that protects cells
from phagocytosis (32). Histoplasma capsulatum chemotype II strains mask -glucan
from immune recognition under an outer layer of -glucan (33). However, simply
masking -glucan by a cell wall outer layer is not sufficient to account for the
phenomenon of lactate-induced -glucan masking in C. albicans because a range of
mannan mutants still display reductions in -glucan exposure in response to lactate
(15). Even in wild-type cells, clearly some glucan escapes mannan-mediated masking to
generate foci of exposure at the C. albicans cell surface (e.g., Fig. 4A).
FIG 7 Inhibition of exoglucanase influences macrophage interactions, cytokine production, and virulence. (A) Mean number of wild-type C. albicans SC5314
cells phagocytosed per murine BMDM in 2 h: DMSO added, vehicle; 1 M castanospermine added, CAS. n 4 mice analyzed in biological triplicate, 200
macrophages counted per coincubation. ****, P 0.0001, one-way ANOVA with Tukey’s post hoc. (B) Wild-type C. albicans cells were grown in glucose or glucose
plus lactate, with or without vehicle or castanospermine (CAS), and fixed. TNF- production was assayed after the fixed C. albicans cells were incubated with
human PBMCs for 24 h. n  3 healthy donors, measured in duplicate. (C) Percent survival of G. mellonella infected with wild-type C. albicans and treated with
vehicle alone or 1 M castanospermine. n 10; *, P 0.05, Kruskal-Wallis log rank test.
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We show that C. albicans expresses a major extracellular exoglucanase, Xog1, in
response to lactate. Xog1 expression both is regulated by the same pathways that
control lactate-induced -glucan masking and is required for this phenotype. Other
activities may contribute to lactate-induced reductions in -glucan exposure (Fig. 3A),
but Xog1 is the major extracellular exoglucanase under these experimental conditions.
Significantly, Xog1 inactivation attenuates immune evasion by preventing the decrease
in phagocytosis rates and the tempering of cytokine elicitation normally associated
with lactate responses in C. albicans. These effects were phenocopied by the pharma-
cological inhibition of exoglucanase by castanospermine, reinforcing the idea that the
Xog1 exoglucanase is a major factor in -glucan masking and manipulates host
immune recognition. The induction of Xog1 by C. albicans in response to lactate is
particularly significant, because this suggests that exoglucanase production is an
anticipatory response that protects the fungus against impending attack by innate
immune cells (34). Given the biochemical role of Xog1, we suggest that this exoglu-
canase “shaves” -glucan epitopes from the C. albicans cell surface, rather than
physically masks them (Fig. 8).
However, XOG1 inactivation does not significantly attenuate virulence in G. mello-
nella (see Fig. S2 in the supplemental material) or significantly reduce kidney burdens
in mice (22). Interestingly, H. capsulatum expresses an endoglucanase, Eng1, which,
together with the outer -1,3-glucan layer, reduces -1,3-glucan exposure and pro-
motes immune evasion by H. capsulatum cells (35). Blocking ENG1 expression in H.
capsulatum only leads to a slight reduction in fungal burden in mice after 8 days of
infection (35).
Clearly, Xog1 plays a major role in lactate-induced -1,3-glucan shaving. Neverthe-
less, we note that our proteomics data sets reveal other glucanases that were differ-
entially regulated in response to lactate. These enzymes could potentially contribute to
PAMP remodeling. Also, we cannot exclude minor roles for other glucanases in vivo
and, in particular, the putative exoglucanase, Exg2, which is transcriptionally induced in
response to lactate. but was not detected in our proteomics data sets (15), and which
might be secreted at elevated levels in vivo. It is also conceivable that environmentally
contingent changes in the outer mannan layer might affect the efficacy with which this
layer masks -glucan. Indeed, the abundance of some cell wall mannoproteins did
change in response to lactate (Table S2). Therefore, while Xog1 plays a major role in
-glucan shaving in vitro, other mechanisms could potentially contribute to the ob-
served changes in -glucan exposure that occur during the adaptation of C. albicans to
certain specific host signals (15–18, 36). Furthermore, we cannot exclude the possibility
that the inactivation of Xog1 influences innate immune responses in some other way,
for example by indirectly influencing the levels of certain cell wall proteins, or enhanc-
ing PAMP recognition by some means.
Is exoglucanase a viable antifungal drug target? Our results show that the inhibition
of exoglucanase with the small molecule castanospermine enhanced immune recog-
nition of C. albicans cells and significantly improved the survival of G. mellonella larvae
FIG 8 Xog1 “shaves” -1,3-glucan to facilitate immune evasion by C. albicans. Top panel: patches of
-1,3-glucan (blue) are accessible to dectin-1 recognition in glucose-grown C. albicans cells. Bottom
panel: specific host inputs induce Xog1 secretion. Xog1 exoglucanase activity (red) shaves exposed
-1,3-glucan, thereby reducing its accessibility to dectin-1 recognition.
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after lethal challenge with the fungus. Although castanospermine does not inhibit
endoglucanase in vitro (24), potential effects upon activities other than exoglucanase
cannot be excluded in vivo. For example, host cells also produce glucanases and
-glucosidases that can be inhibited by castanospermine, leading to mammalian
toxicity (26). Less toxic derivatives of castanospermine are under development for the
treatment of viral infections, including dengue fever (37). These drugs are thought to
inhibit viral protein folding by blocking the trimming of N-linked carbohydrates (38).
Taken together, the data suggest that the development of fungus-specific exogluca-
nase inhibitors might provide a new therapeutic avenue to augment current antifungal
treatments.
MATERIALS AND METHODS
Strains and growth conditions. Strains used in this study are listed in Table S1 in the supplemental
material. Strains were cultured routinely on YPD agar (1% yeast extract, 2% Bacto peptone, 2% glucose,
and 2% Bacto agar) at 30°C. For -glucan masking experiments, strains were grown at 30°C, 200 rpm,
overnight in yeast nitrogen base without amino acids (BD Difco; 6.7 g/liter) containing the appropriate
supplements, plus 2% glucose (YNB-Glu) and then diluted to an OD600 of 0.1 in fresh YNB-Glu with and
without 2% D/L-lactate (Sigma) and grown 5 h at 30°C, 200 rpm. To prepare hypoxic cultures, cells were
inoculated into YNB-Glu in a screw-cap conical flask under nitrogen (16). Cells treated with castanosper-
mine (Cayman Chemical) were grown as described above for -glucan masking experiments with the
addition of castanospermine (in dimethyl sulfoxide [DMSO]) to a final concentration of 1 M.
Strain construction. Heterozygous (XOG1/xog1Δ) and homozygous (xog1Δ/xog1Δ) C. albicans mu-
tants were constructed sequentially using the SAT1 flipper (39). Briefly, upstream and downstream
flanking regions to the XOG1 open reading frame were amplified using primers 1 to 4 listed in Table S1
and cloned into the SAT1 flipper plasmid between the NotI/SacII and KpnI/XhoI restriction sites,
respectively. The resultant plasmid was digested with KpnI/SacII to release the disruption cassette, which
was then purified by gel extraction (Qiagen) and transformed into C. albicans SC5314 using a lithium
acetate protocol (40). C. albicans reintegrant strains (xog1Δ/xog1Δ/XOG1) were constructed by amplifying
2 kb of XOG1 promoter region, the open reading frame, and terminator from C. albicans SC5314 genomic
DNA and cloning the PCR product into plasmid CIp-NAT at the NotI/SacII restriction sites (41). The
resulting plasmid was linearized with StuI and transformed into the xog1Δ/xog1Δ mutant for integration
at the RPS1 locus. Mutant genotypes were confirmed by colony PCR.
Proteomics. C. albicans wild-type (SC5314), crz1Δ, and gpr1Δ gpa2Δ strains were grown for 5 h in
YNB-Glu, YNB-Glu plus Lac, or YNB-Glu under hypoxic conditions to induce -glucan masking. Cell wall
extracts were prepared from cells by an SDS boiling procedure (42). Briefly, cells were washed twice with
4°C distilled water (dH2O) and broken with 400- to 600-nm acid-washed glass beads using a FastPrep
machine (MP Biomedical). Cell homogenates were pelleted and washed in 1 M NaCl and resuspended in
SDS extraction buffer (50 mM Tris-HCl, pH 7.5, 2% SDS, 0.3 M -mercaptoethanol, and 1 mM EDTA).
Homogenates were boiled at 100°C for 10 min, washed with dH2O, and freeze-dried. Cell wall protein
extracts (lyophilized, 1 mg) or secreted proteins (approximately 10 g) were resuspended in 100 l
ammonium bicarbonate (50 mM) in 1.5-ml low-binding tubes. Reduction was performed by the addition
of 2 l dithiothreitol (DTT; 200 mM) with incubation for 30 min at 60°C and then alkylation by the
addition of 4 l iodoacetamide (200 mM) with incubation in the dark for 30 min at 25°C. Proteins were
digested by the addition of 10 l sequencing-grade trypsin (20 g/ml, Promega) with incubation
overnight at 37°C. Digested cell wall samples were centrifuged at 17,000	 g, and the supernatants were
transferred to clean tubes. The pellets were resuspended in 50 l 0.1% (vol/vol) trifluoroacetic acid
(TFA)-70% (vol/vol) acetonitrile in ultrapure water, shaken for 10 min, and centrifuged again, and the
supernatants were added to those already taken. All digests were frozen at 70°C and dried by vacuum
centrifugation (SpeedVac SC110A; Savant). Peptides were dissolved in 40 l 0.1% TFA, desalted on -C18
ZipTips (Merck Millipore, Watford, United Kingdom), and dried by vacuum centrifugation.
Desalted peptide samples were dissolved in 10 l loading solvent (0.1% [vol/vol] formic acid, 2%
[vol/vol] acetonitrile in ultrapure water). Liquid chromatography-tandem mass spectrometry was per-
formed using a Q Exactive Plus/Ultimate 3000 RSLCnano system (Thermo Scientific, Hemel Hempstead,
United Kingdom). Sample (5 l) was loaded onto a trapping column (C18 PepMap 100; 300-m inside
diameter [i.d.] by 5 mm) for 5 min at 10 l/min and reverse-flushed to the nanocolumn (PepMap RSLC
C18; 75-m i.d. by 25 cm) at 300 l/min using a gradient of various proportions of solvent A (0.1% formic
acid in ultrapure water) and solvent B (0.1% formic acid, 80% acetonitrile in ultrapure water). The
proportion of solvent B was increased from 3 to 10% during 5 to 10 min, from 10 to 40% during 10 to
40 min, and from 40 to 80% during 40 to 45 min; held at 80% during 45 to 53 min; and then returned
to 3%. Mass spectra were acquired during 5 to 65 min in full MS/data-dependent MS2 mode using a “Top
10” method. MS1 scans were performed from 375 to 1,750 m/z with a resolution of 70,000, an automatic
gain control (AGC) target of 3e6, and maximum injection time (max IT) of 50 ms. The 10 most abundant
precursor ions with charge states of2 to5 were selected from each MS1 scan for sequential trapping
and fragmentation by higher-energy collisional dissociation (normalized collision energy 26%). MS2
scans were performed with a resolution of 17,500, an AGC target of 5e4, and max IT of 100 ms. Previously
selected ions were dynamically excluded for 40 s, and peptide ions were preferred.
Raw data files from the Q Exactive Plus were processed using Proteome Discoverer v1.4 (Thermo
Scientific) with Mascot v2.5 (Matrix Science, London, United Kingdom) as the search engine. The database
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comprised 12,421 protein sequences in the file C_albicans_SC5314_A22_current_orf_trans_all.fasta
downloaded from the Candida Genome Database (www.candidagenome.org, datestamp 2016-02-19).
Search parameters were: enzyme  trypsin; maximum missed cleavage sites 2; instrument  electro-
spray ionization Fourier transform ion cyclotron resonance (ESI-FTICR); precursor mass toler-
ance 10 ppm; fragment mass tolerance 20 millimass units (mmu); dynamic modifications  oxida-
tion (M); static modifications  carbamidomethyl (C). Results were filtered for peptides with a Mascot
significance value of 0.05, and protein area values were based on the extracted ion chromatograms of
the three most abundant peptides. Peptide-spectrum matches were validated using a decoy database
search with target false-discovery rates of 0.01 (strict) and 0.05 (relaxed). To perform a semiquantitative
analysis, the number of detected peptides for each protein was divided by the total number of peptides
detected for the respective biological replicate and multiplied by 100 to obtain the percent spectral
count. Percent spectral counts were averaged between biological replicates to calculate percent spectral
means for each protein.
Flow cytometry. Cells were inactivated overnight at room temperature in 50 mM thimerosal, washed
three times and resuspended in phosphate-buffered saline (PBS), and counted by hemocytometer (15).
Then, 2.5	 106 cells were washed in fluorescence-activated cell sorting (FACS) buffer (PBS containing 1%
fetal bovine serum [FBS], 0.5 mM EDTA) and stained with Fc-dectin-1 and goat (Gt) F(ab=)2 anti-human
IgG conjugated to Alexa Fluor 488 (Invitrogen), and 10,000 cells from each experiment were analyzed by
either FACSCalibur or BD Fortessa. The data represent three biological replicates for each condition.
Microscopy. For microscopy, cells were inactivated and stained as described above for flow
cytometry with the addition of concanavalin A conjugated to Texas Red (Invitrogen) to stain cell wall
mannan. Cells were imaged using phase-contrast and fluorescence microscopy on a Zeiss Axioplan 2
microscope. Images were captured with a Hamamatsu C4742-95 digital camera (Hamamatsu Photonics)
and recorded using Zeiss Zen software (Oberkochen, Germany).
Exoglucanase assay. Exoglucanase activity was determined by a para-nitrophenol--D-gluco-
pyranoside (PNPG; Sigma) cleavage assay (23). Cell supernatants (10 ml) were filtered and concentrated
to 1 ml on 10-kDa-cutoff Vivaspin protein concentrator columns (GE Healthcare and Life Sciences) and
washed in 50 mM sodium acetate, pH 5.3. One hundred twenty-five microliters of concentrated super-
natant was coincubated with an equal volume of PNPG (5 mg/ml in 50 mM sodium acetate, pH 5.3) for
16 h at 37°C. Reactions were stopped with 2.25 ml of Na2CO3 (40 g/liter), the absorbance was measured
at 410 nm, and values were normalized to cell density. Assays were performed in duplicate, and blanks
(250 l 50 mM sodium acetate, pH 5.3) and negative controls (equal volumes 50 mM sodium acetate, pH
5.3, and PNPG) were included. Relative exoglucanase activities were calculated as follows: (normalized
A
410 GluLac
/normalized A410 Glu) 	 100. Strains were assayed in biological triplicate.
Supernatant complementation. C. albicans wild-type (SC5314) and czf1 cells were grown over-
night in 5 ml YNB-Glu at 30°C, 200 rpm. The wild-type cells were diluted to an OD600 of 0.1 into 50 ml
fresh YNB-Glu with or without 2% D/L-lactate and cultured at 30°C, 200 rpm, for 4 h, and at this point, cells
in one portion of the culture were inactivated in 50 mM thimerosal for analysis. The supernatant from the
other portion of the culture was passed through a 0.45-m syringe filter: one-half was used directly, and
the other half was boiled at 100°C for 15 min and cooled on ice. The C. albicans czf1 cells were diluted
to an OD600 of 0.1 in this spent-boiled medium, in the spent-untreated medium, or in fresh medium
that had been prewarmed to 30°C and were incubated for 4 h at 30°C, 200 rpm. Cells were then harvested
and inactivated in 50 mM thimerosal for flow cytometry (above).
Macrophage interactions. Bone marrow-derived macrophages (BMDMs) were prepared from the
femurs and tibias of 12-week-old male C57BL/6 mice. BMDMs were differentiated for 7 days in Dulbecco’s
modified Eagle’s medium (DMEM; Gibco) containing 10% heat-inactivated fetal calf serum supplemented
with 15% L-cell conditioned medium (43). C. albicans cells grown in glucose plus lactate or glucose alone
were inactivated with thimerosal, mixed with the BMDMs at a ratio of 3:1 (yeast cells to macrophages),
and imaged at 2-min intervals for 2 h using a Nikon Eclipse Ti UltraVIEW VoX spinning disk microscope
with Volocity software (Quorum Technologies, ON, Canada). The number of C. albicans cells engulfed per
macrophage was quantified over 2 h. The difference in engulfment between conditions was determined
in GraphPad Prism 8 using one-way ANOVA with Tukey’s post hoc test.
Cytokine measurements. PBMCs were prepared from nonheparinized whole blood (40 ml) collected
from three healthy volunteers by Ficoll-Paque centrifugation according to the manufacturer’s instruc-
tions (Sigma-Aldrich). Thimerosal-fixed C. albicans cells were washed thrice with sterile PBS and incu-
bated for 24 h with PBMCs (5:1, yeast to PBMCs). The coincubation supernatant was collected, and
specific cytokines were quantified with a Luminex screening kit (R&D Systems) in the Bioplex 200 system
(Bio-Rad) according to the manufacturer’s instructions.
Galleria mellonella infections. Galleria larvae were acquired from BioSystems Technology and
stored with wood shavings in the dark at 20°C prior to the experiment. C. albicans wild-type (SC5314)
cells were grown overnight, diluted into fresh glucose medium, and grown for a further 5 h to reach
exponential phase. Cells were collected by centrifugation, washed thrice in PBS, and resuspended in
sterile PBS. Groups of 10 G. mellonella larvae (300-mg weight) were inoculated with a 50-l suspension
of 5	 105 C. albicans yeast cells in the last left proleg (27). Larvae received a second 50-l injection of either
1M castanospermine or vehicle in the last right proleg. Injections were delivered with U-100 30G BD
Micro-fine syringes (BD). Control groups of five larvae received PBS alone or PBS and castanospermine
injections in 50-l suspensions. The larvae were then incubated in the dark at 37°C, and survival was assessed
every 2 to 4 h thereafter. No larvae in the control group died over the course of the experiment. Survival
experiments were terminated approximately 5 days postinfection. The virulence of xog1 cells was assessed
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as described above, with the following modification: G. mellonella larvae were inoculated with a 50-l
suspension of 1	 105 C. albicans wild-type (SC5314) or xog1 yeast cells in the last left proleg.
Statistics. G. mellonella survival was assessed by Mantel-Cox test using SPSS software. All other
statistical analyses were performed using GraphPad Prism 8 software.
Ethics. This study complies with all relevant ethical regulations for experiments with human
participant samples. Donor blood was collected from healthy volunteers with their informed consent
according to local guidelines and regulations that were approved by the College Ethics Review Board of
the University of Aberdeen (CERB/2016/8/1300). Animal usage was approved by the University of
Aberdeen Animal Welfare and Ethical Review body. Mice were bred in-house, housed in stock cages
under specific-pathogen-free conditions, and selected at random. Animals did not undergo any regu-
lated procedures prior to culling by cervical dislocation.
Data availability. The data supporting the findings in this study are available within the paper and
accompanying supplemental material. The mass spectrometry proteomics data have been deposited to
the ProteomeXchange Consortium via the PRIDE (44) partner repository with the data set identifiers
PXD018027 and PXD018044.
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